Pediatric Gastroenterology, Hepatology and Nutrition Fellowship
The Pediatric Gastroenterology Fellowship is led by Program Director Brian McFerron, MD, and Fellowship Coordinator Kori Nelson.
Fellows are on clinical service for five of the twelve months. One month is spent in the outpatient GI clinic and endoscopy suite. Five months are spent on the inpatient service where fellows oversee the performance of the pediatric house officers and students in the management of all inpatients. Fellows provide inpatient consultation services, along with faculty. Additional months are spent in the departments of Radiology/Pathology, Nutritional Support, Transplant Hepatology, and GI Subspecialty Clinics. Two months during the first year are academic months to be spent in research or in manuscript preparation. Continuity clinics are held 1-2 half-days a week during non-service months. GI/Pathology Conferences are conducted twice monthly along with division teaching conferences. Monthly conferences include Research Conference, GI/General Surgery/Radiology Conference, Improve Care Now Conference, Fellow’s Didactic Conference and Journal Club. Morbidity and Mortality Conference, in addition to the GI/Pulmonology Conference are held quarterly.
Fellows are on the clinical service for four of the twelve months. Two additional core rotations include Advanced Clinical Elective and Advanced Procedures/Surgery. The remaining six months are devoted to academic growth in their research area. Fellows will attend 1-2 half-day continuity clinics per week during non-service months.
Two of the twelve months are spent on the clinical service. The remaining ten months will be solely devoted to the completion of research activities. Fellows will attend two half-day continuity clinics per week during non-service months.
Primary research in the Division of Gastroenterology, Hepatology and Nutrition centers on reflux esophagitis, esophageal pH monitoring, eosinophilic esophagitis, inflammatory bowel disease, gastrointestinal motility, hepatitis B and C, cholestatic liver disease, steatohepatitis, Cystic Fibrosis liver disease, short bowel syndrome/intestinal rehabilitation, pancreatitis and quality improvement.